VNDA - Vanda under pressure from hedge fund to discuss Future Pak takeover offer
2024-04-19 15:56:27 ET
More on Vanda Pharmaceuticals
- Vanda Pharmaceuticals: Fanapt Bipolar Win Doesn't Change Much
- Vanda Pharmaceuticals' Portfolio Likely Has Upside From 2024 Approvals, Underpinned By Cash
- Vanda Pharmaceuticals Inc. (VNDA) Q4 2023 Earnings Call Transcript
- Vanda Pharmaceuticals rejects Future Pak's latest buy offer (updated)
- Vanda stock jumps as FDA approves Fanapt tablets for bipolar disorder